Search

Your search keyword '"Sun, Zhifu"' showing total 802 results
Start Over Author "Sun, Zhifu"
802 results on '"Sun, Zhifu"'

3. Hypoxia-Inducible Factor 1α Stabilization Restores Epigenetic Control of Nitric Oxide Synthase 1 Expression and Reverses Gastroparesis in Female Diabetic Mice

Author

Gao, Fei, Hayashi, Yujiro, Saravanaperumal, Siva Arumugam, Gajdos, Gabriella B., Syed, Sabriya A., Bhagwate, Aditya V., Ye, Zhenqing, Zhong, Jian, Zhang, Yuebo, Choi, Egan L., Kvasha, Sergiy M., Kaur, Jagneet, Paradise, Brooke D., Cheng, Liang, Simone, Brandon W., Wright, Alec M., Kellogg, Todd A., Kendrick, Michael L., McKenzie, Travis J., Sun, Zhifu, Yan, Huihuang, Yu, Chuanhe, Bharucha, Adil E., Linden, David R., Lee, Jeong-Heon, and Ordog, Tamas

Published
2023
Full Text
View/download PDF

5. G9a Modulates Lipid Metabolism in CD4 T Cells to Regulate Intestinal Inflammation

Author

Ramos, Guilherme Piovezani, Bamidele, Adebowale O., Klatt, Emily E., Sagstetter, Mary R., Kurdi, Ahmed T., Hamdan, Feda H., Kosinsky, Robyn Laura, Gaballa, Joseph M., Nair, Asha, Sun, Zhifu, Dasari, Surendra, Lanza, Ian R., Rozeveld, Cody N., Schott, Micah B., Urrutia, Guillermo, Westphal, Maria S., Clarkson, Benjamin D., Howe, Charles L., Marietta, Eric V., Luckey, David H., Murray, Joseph A., Gonzalez, Michelle, Braga Neto, Manuel B., Gibbons, Hunter R., Smyrk, Thomas C., Johnsen, Steven, Lomberk, Gwen, and Faubion, William A.

Published
2023
Full Text
View/download PDF

6. Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer

Author

Aspros, Kirsten G. M., Carter, Jodi M., Hoskin, Tanya L., Suman, Vera J., Subramaniam, Malayannan, Emch, Michael J., Ye, Zhenqing, Sun, Zhifu, Sinnwell, Jason P., Thompson, Kevin J., Tang, Xiaojia, Rodman, Esther P. B., Wang, Xiyin, Nelson, Adam W., Chernukhin, Igor, Hamdan, Feda H., Bruinsma, Elizabeth S., Carroll, Jason S., Fernandez-Zapico, Martin E., Johnsen, Steven A., Kalari, Krishna R., Huang, Haojie, Leon-Ferre, Roberto A., Couch, Fergus J., Ingle, James N., Goetz, Matthew P., and Hawse, John R.

Published
2022
Full Text
View/download PDF

10. An investigation of plasma cell-free RNA for the detection of colorectal cancer: From transcriptome marker selection to targeted validation.

Author

Northrop-Albrecht, Emmalee J., Wu, Chung Wah, Berger, Calise K., Taylor, William R., Foote, Patrick H., Doering, Karen A., Gonser, Anna M., Bhagwate, Aditya, Sun, Zhifu, Mahoney, Douglas W., Burger, Kelli N., Boardman, Lisa A., and Kisiel, John B.

Subjects
COLORECTAL cancer, RNA sequencing, INDEPENDENT sets, EARLY detection of cancer, DATA analysis
Abstract

Regular screening for colorectal cancer (CRC) is critical for early detection and long-term survival. Despite the current screening options available and advancements in therapies there will be around 53,000 CRC related deaths this year. There is great interest in non-invasive alternatives such as plasma cell-free RNA (cfRNA) for diagnostic, prognostic, and predictive applications. In the current study, our aim was to identify and validate potential cfRNA candidates to improve early CRC diagnosis. In phase 1 (n = 49; 25 controls, 24 cancers), discovery total RNA sequencing was performed. Select exons underwent validation in phase 2 (n = 73; 35 controls, 29 cancers, 9 adenomas) using targeted capture sequencing (n = 10,371 probes). In phase 3 (n = 57; 30 controls, 27 cancers), RT-qPCR was performed on previously identified candidates (n = 99). There were 895 exons that were differentially expressed (325 upregulated, 570 downregulated) among cancers versus controls. In phases 2 and 3, fewer markers were validated than expected in independent sets of patients, most of which were from previously published literature (FGA, FGB, GPR107, CDH3, and RP23AP7). In summary, we optimized laboratory processes and data analysis strategies which can serve as methodological framework for future plasma RNA studies beyond just the scope of CRC detection. Additionally, further exploration is needed in order to determine if the few cfRNA candidates identified in this study have clinical utility for early CRC detection. Over time, advancements in technologies, data analysis, and RNA preservation methods at time of collection may improve the biological and technical reproducibility of cfRNA biomarkers and enhance the feasibility of RNA-based liquid biopsies. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

15. Corrigendum to “Host immunity and KLF 11 deficiency together promote fibrosis in a mouse model of endometriosis” [BBA - Mol. Basis of Dis. 1869 (2023) 166784]

Author

Grande, Joseph, primary, Jones, Tiffanny L., additional, Sun, Zhifu, additional, Chanana, Pritha, additional, Jaiswal, Indu, additional, Leontovich, Alexey, additional, Carapanceanu, Nicoletta, additional, Carapanceanu, Valentin, additional, Saadalla, Abdulrahman, additional, Osman, Abu, additional, Famuyide, Abimbola O., additional, Daftary, Gaurang S., additional, Khan, Zaraq, additional, and Khazaie, Khashayarsha, additional

Published
2023
Full Text
View/download PDF

17. Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements

Author

Luchtel, Rebecca A., Dasari, Surendra, Oishi, Naoki, Pedersen, Martin Bjerregård, Hu, Guangzhen, Rech, Karen L., Ketterling, Rhett P., Sidhu, Jagmohan, Wang, Xueju, Katoh, Ryohei, Dogan, Ahmet, Kip, N. Sertac, Cunningham, Julie M., Sun, Zhifu, Baheti, Saurabh, Porcher, Julie C., Said, Jonathan W., Jiang, Liuyan, Hamilton-Dutoit, Stephen Jacques, Møller, Michael Boe, Nørgaard, Peter, Bennani, N. Nora, Chng, Wee-Joo, Huang, Gaofeng, Link, Brian K., Facchetti, Fabio, Cerhan, James R., d'Amore, Francesco, Ansell, Stephen M., and Feldman, Andrew L.

Published
2018
Full Text
View/download PDF

21. Comparison of tagging single-nucleotide polymorphism methods in association analyses

Author

Goode, Ellen L, Fridley, Brooke L, Sun, Zhifu, Atkinson, Elizabeth J, Nord, Alex S, McDonnell, Shannon K, Jarvik, Gail P, de Andrade, Mariza, and Slager, Susan L

Subjects
Epidemiology, Biological Sciences, Health Sciences, Genetics, 2.1 Biological and endogenous factors, Aetiology
Abstract

Several methods to identify tagging single-nucleotide polymorphisms (SNPs) are in common use for genetic epidemiologic studies; however, there may be loss of information when using only a subset of SNPs. We sought to compare the ability of commonly used pairwise, multimarker, and haplotype-based tagging SNP selection methods to detect known associations with quantitative expression phenotypes. Using data from HapMap release 21 on unrelated Utah residents with ancestors from northern and western Europe (CEPH-Utah, CEU), we selected tagging SNPs in five chromosomal regions using ldSelect, Tagger, and TagSNPs. We found that SNP subsets did not substantially overlap, and that the use of trio data did not greatly impact SNP selection. We then tested associations between HapMap genotypes and expression phenotypes on 28 CEU individuals as part of Genetic Analysis Workshop 15. Relative to the use of all SNPs (n = 210 SNPs across all regions), most subset methods were able to detect single-SNP and haplotype associations. Generally, pairwise selection approaches worked extremely well, relative to use of all SNPs, with marked reductions in the number of SNPs required. Haplotype-based approaches, which had identified smaller SNP subsets, missed associations in some regions. We conclude that the optimal tagging SNP method depends on the true model of the genetic association (i.e., whether a SNP or haplotype is responsible); unfortunately, this is often unknown at the time of SNP selection. Additional evaluations using empirical and simulated data are needed.

Published
2007

24. BMI1 maintains the Treg epigenomic landscape to prevent inflammatory bowel disease

Author

Gonzalez, Michelle M., Bamidele, Adebowale O., Svingen, Phyllis A., Sagstetter, Mary R., Smyrk, Thomas C., Gaballa, Joseph M., Hamdan, Feda H., Kosinsky, Robyn Laura, Gibbons, Hunter R., Sun, Zhifu, Ye, Zhenqing, Nair, Asha, Ramos, Guilherme P., Neto, Manuel B. Braga, Wixom, Alexander Q., Mathison, Angela J., Johnsen, Steven A., Urrutia, Raul, and Faubion, William A., Jr.

Subjects
Suppressor cells -- Health aspects, Genetic research, Inflammatory bowel diseases -- Development and progression -- Genetic aspects, Epigenetic inheritance -- Research, Oncogenes -- Health aspects, Health care industry
Abstract

[FOXP3.sup.+] Tregs are expanded within the inflamed intestine of human Crohn's disease, yet FOXP3-mediated gene repression within these cells is lost. The polycomb repressive complexes play a role in FOXP3 target gene regulation, but deeper mechanistic insight is incomplete. We have now specifically identified the polycomb-repressive complex 1 (PRC1) family member, BMI1 in the regulation of a proinflammatory enhancer network in both human and murine Tregs. Using human Tregs and lamina propria T cells, we inferred PRC1 to regulate Crohn's associated gene networks through assays of chromatin accessibility. Conditional deletion of BMI1 in murine [FOXP3.sup.+] cells led to systemic inflammation. BMI1- deficient Tregs beared a TH1/TH17-like phenotype as assessed by assays of genome wide transcription, chromatin accessibility and proteomic techniques. Finally, BMI1 mutant [FOXP3.sup.+] cells did not suppress colitis in the adoptive transfer model of human inflammatory bowel disease. We propose that BMI1 plays an important role in enforcing Treg identity in vitro and in vivo. Loss of Treg identity via genetic or transient BMI1 depletion perturbs the epigenome and converts Tregs into Th1/Th17- like proinflammatory cells, a transition relevant to human Crohn's disease associated [CD4.sup.+] T cells., Introduction Persistent activation of pathogenic adaptive immune cells is evident in many autoimmune diseases, including inflammatory bowel disease (IBD, including Crohn's disease, CD, and ulcerative colitis [UC], refs. 1-3). In [...]

Published
2021
Full Text
View/download PDF

26. Supplementary Table 2 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer

Author

de Andrade, Mariza, primary, Li, Yan, primary, Marks, Randolph S., primary, Deschamps, Claude, primary, Scanlon, Paul D., primary, Olswold, Curtis L., primary, Jiang, Ruoxiang, primary, Swensen, Stephen J., primary, Sun, Zhifu, primary, Cunningham, Julie M., primary, Wampfler, Jason A., primary, Limper, Andrew H., primary, Midthun, David E., primary, and Yang, Ping, primary

Published
2023
Full Text
View/download PDF

27. Data from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer

Author

de Andrade, Mariza, primary, Li, Yan, primary, Marks, Randolph S., primary, Deschamps, Claude, primary, Scanlon, Paul D., primary, Olswold, Curtis L., primary, Jiang, Ruoxiang, primary, Swensen, Stephen J., primary, Sun, Zhifu, primary, Cunningham, Julie M., primary, Wampfler, Jason A., primary, Limper, Andrew H., primary, Midthun, David E., primary, and Yang, Ping, primary

Published
2023
Full Text
View/download PDF

28. Supplementary Table 3 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer

Author

de Andrade, Mariza, primary, Li, Yan, primary, Marks, Randolph S., primary, Deschamps, Claude, primary, Scanlon, Paul D., primary, Olswold, Curtis L., primary, Jiang, Ruoxiang, primary, Swensen, Stephen J., primary, Sun, Zhifu, primary, Cunningham, Julie M., primary, Wampfler, Jason A., primary, Limper, Andrew H., primary, Midthun, David E., primary, and Yang, Ping, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Table 1 from Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer

Author

de Andrade, Mariza, primary, Li, Yan, primary, Marks, Randolph S., primary, Deschamps, Claude, primary, Scanlon, Paul D., primary, Olswold, Curtis L., primary, Jiang, Ruoxiang, primary, Swensen, Stephen J., primary, Sun, Zhifu, primary, Cunningham, Julie M., primary, Wampfler, Jason A., primary, Limper, Andrew H., primary, Midthun, David E., primary, and Yang, Ping, primary

Published
2023
Full Text
View/download PDF

30. Data from Fine Mapping of Chromosome 6q23-25 Region in Familial Lung Cancer Families Reveals RGS17 as a Likely Candidate Gene

Author

You, Ming, primary, Wang, Daolong, primary, Liu, Pengyuan, primary, Vikis, Haris, primary, James, Michael, primary, Lu, Yan, primary, Wang, Yian, primary, Wang, Min, primary, Chen, Qiong, primary, Jia, Dongmei, primary, Liu, Yan, primary, Wen, Weidong, primary, Yang, Ping, primary, Sun, Zhifu, primary, Pinney, Susan M., primary, Zheng, Wei, primary, Shu, Xiao-Ou, primary, Long, Jirong, primary, Gao, Yu-Tang, primary, Xiang, Yong-Bing, primary, Chow, Wong-Ho, primary, Rothman, Nat, primary, Petersen, Gloria M., primary, de Andrade, Mariza, primary, Wu, Yanhong, primary, Cunningham, Julie M., primary, Wiest, Jonathan S., primary, Fain, Pamela R., primary, Schwartz, Ann G., primary, Girard, Luc, primary, Gazdar, Adi, primary, Gaba, Colette, primary, Rothschild, Henry, primary, Mandal, Diptasri, primary, Coons, Teresa, primary, Lee, Juwon, primary, Kupert, Elena, primary, Seminara, Daniela, primary, Minna, John, primary, Bailey-Wilson, Joan E., primary, Amos, Christopher I., primary, and Anderson, Marshall W., primary

Published
2023
Full Text
View/download PDF

31. Supplementary Tables 1-4 from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy

Author

Li, Yafei, primary, Sun, Zhifu, primary, Cunningham, Julie M., primary, Aubry, Marie C., primary, Wampfler, Jason A., primary, Croghan, Gary A., primary, Johnson, Cassandra, primary, Wu, Danli, primary, Aakre, Jeremiah A., primary, Molina, Julian, primary, Wang, Liewei, primary, Pankratz, V. Shane, primary, and Yang, Ping, primary

Published
2023
Full Text
View/download PDF

32. Supplemental Figures 1-6 from New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice

Author

Kisiel, John B., primary, Raimondo, Massimo, primary, Taylor, William R., primary, Yab, Tracy C., primary, Mahoney, Douglas W., primary, Sun, Zhifu, primary, Middha, Sumit, primary, Baheti, Saurabh, primary, Zou, Hongzhi, primary, Smyrk, Thomas C., primary, Boardman, Lisa A., primary, Petersen, Gloria M., primary, and Ahlquist, David A., primary

Published
2023
Full Text
View/download PDF

33. Supplemental Table 2 from New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice

Author

Kisiel, John B., primary, Raimondo, Massimo, primary, Taylor, William R., primary, Yab, Tracy C., primary, Mahoney, Douglas W., primary, Sun, Zhifu, primary, Middha, Sumit, primary, Baheti, Saurabh, primary, Zou, Hongzhi, primary, Smyrk, Thomas C., primary, Boardman, Lisa A., primary, Petersen, Gloria M., primary, and Ahlquist, David A., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Figure 1 from Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers

Author

Jang, Jin Sung, primary, Jeon, Hyo-Sung, primary, Sun, Zhifu, primary, Aubry, Marie Christine, primary, Tang, Hui, primary, Park, Cheol-Hong, primary, Rakhshan, Fariborz, primary, Schultz, Debra A., primary, Kolbert, Christopher P., primary, Lupu, Ruth, primary, Park, Jae Yong, primary, Harris, Curtis C., primary, Yang, Ping, primary, and Jen, Jin, primary

Published
2023
Full Text
View/download PDF

35. Supplementary Data from Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma

Author

Qin, Yi, primary, Wu, Chung W., primary, Taylor, William R., primary, Sawas, Tarek, primary, Burger, Kelli N., primary, Mahoney, Douglas W., primary, Sun, Zhifu, primary, Yab, Tracy C., primary, Lidgard, Graham P., primary, Allawi, Hatim T., primary, Buttar, Navtej S., primary, Smyrk, Thomas C., primary, Iyer, Prasad G., primary, Katzka, David A., primary, Ahlquist, David A., primary, and Kisiel, John B., primary

Published
2023
Full Text
View/download PDF

36. Translation on this Article from Fine Mapping of Chromosome 6q23-25 Region in Familial Lung Cancer Families Reveals RGS17 as a Likely Candidate Gene

Author

You, Ming, primary, Wang, Daolong, primary, Liu, Pengyuan, primary, Vikis, Haris, primary, James, Michael, primary, Lu, Yan, primary, Wang, Yian, primary, Wang, Min, primary, Chen, Qiong, primary, Jia, Dongmei, primary, Liu, Yan, primary, Wen, Weidong, primary, Yang, Ping, primary, Sun, Zhifu, primary, Pinney, Susan M., primary, Zheng, Wei, primary, Shu, Xiao-Ou, primary, Long, Jirong, primary, Gao, Yu-Tang, primary, Xiang, Yong-Bing, primary, Chow, Wong-Ho, primary, Rothman, Nat, primary, Petersen, Gloria M., primary, de Andrade, Mariza, primary, Wu, Yanhong, primary, Cunningham, Julie M., primary, Wiest, Jonathan S., primary, Fain, Pamela R., primary, Schwartz, Ann G., primary, Girard, Luc, primary, Gazdar, Adi, primary, Gaba, Colette, primary, Rothschild, Henry, primary, Mandal, Diptasri, primary, Coons, Teresa, primary, Lee, Juwon, primary, Kupert, Elena, primary, Seminara, Daniela, primary, Minna, John, primary, Bailey-Wilson, Joan E., primary, Amos, Christopher I., primary, and Anderson, Marshall W., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Figure 3C from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy

Author

Li, Yafei, primary, Sun, Zhifu, primary, Cunningham, Julie M., primary, Aubry, Marie C., primary, Wampfler, Jason A., primary, Croghan, Gary A., primary, Johnson, Cassandra, primary, Wu, Danli, primary, Aakre, Jeremiah A., primary, Molina, Julian, primary, Wang, Liewei, primary, Pankratz, V. Shane, primary, and Yang, Ping, primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure 2B from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy

Author

Li, Yafei, primary, Sun, Zhifu, primary, Cunningham, Julie M., primary, Aubry, Marie C., primary, Wampfler, Jason A., primary, Croghan, Gary A., primary, Johnson, Cassandra, primary, Wu, Danli, primary, Aakre, Jeremiah A., primary, Molina, Julian, primary, Wang, Liewei, primary, Pankratz, V. Shane, primary, and Yang, Ping, primary

Published
2023
Full Text
View/download PDF

39. Supplementary Figure 1C from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy

Author

Li, Yafei, primary, Sun, Zhifu, primary, Cunningham, Julie M., primary, Aubry, Marie C., primary, Wampfler, Jason A., primary, Croghan, Gary A., primary, Johnson, Cassandra, primary, Wu, Danli, primary, Aakre, Jeremiah A., primary, Molina, Julian, primary, Wang, Liewei, primary, Pankratz, V. Shane, primary, and Yang, Ping, primary

Published
2023
Full Text
View/download PDF

41. Data from Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy

Author

Tan, Xiang-Lin, primary, Moyer, Ann M., primary, Fridley, Brooke L., primary, Schaid, Daniel J., primary, Niu, Nifang, primary, Batzler, Anthony J., primary, Jenkins, Gregory D., primary, Abo, Ryan P., primary, Li, Liang, primary, Cunningham, Julie M., primary, Sun, Zhifu, primary, Yang, Ping, primary, and Wang, Liewei, primary

Published
2023
Full Text
View/download PDF

42. Supplemental Table 1 from New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice

Author

Kisiel, John B., primary, Raimondo, Massimo, primary, Taylor, William R., primary, Yab, Tracy C., primary, Mahoney, Douglas W., primary, Sun, Zhifu, primary, Middha, Sumit, primary, Baheti, Saurabh, primary, Zou, Hongzhi, primary, Smyrk, Thomas C., primary, Boardman, Lisa A., primary, Petersen, Gloria M., primary, and Ahlquist, David A., primary

Published
2023
Full Text
View/download PDF

43. Data from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy

Author

Li, Yafei, primary, Sun, Zhifu, primary, Cunningham, Julie M., primary, Aubry, Marie C., primary, Wampfler, Jason A., primary, Croghan, Gary A., primary, Johnson, Cassandra, primary, Wu, Danli, primary, Aakre, Jeremiah A., primary, Molina, Julian, primary, Wang, Liewei, primary, Pankratz, V. Shane, primary, and Yang, Ping, primary

Published
2023
Full Text
View/download PDF

44. Supplemental legend from Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors

Author

Asiedu, Michael K., primary, Thomas, Charles F., primary, Dong, Jie, primary, Schulte, Sandra C., primary, Khadka, Prasidda, primary, Sun, Zhifu, primary, Kosari, Farhad, primary, Jen, Jin, primary, Molina, Julian, primary, Vasmatzis, George, primary, Kuang, Ray, primary, Aubry, Marie Christine, primary, Yang, Ping, primary, and Wigle, Dennis A., primary

Published
2023
Full Text
View/download PDF

45. Supplementary Table 1 from Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers

Author

Jang, Jin Sung, primary, Jeon, Hyo-Sung, primary, Sun, Zhifu, primary, Aubry, Marie Christine, primary, Tang, Hui, primary, Park, Cheol-Hong, primary, Rakhshan, Fariborz, primary, Schultz, Debra A., primary, Kolbert, Christopher P., primary, Lupu, Ruth, primary, Park, Jae Yong, primary, Harris, Curtis C., primary, Yang, Ping, primary, and Jen, Jin, primary

Published
2023
Full Text
View/download PDF

47. Supplementary Table 2 from Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers

Author

Jang, Jin Sung, primary, Jeon, Hyo-Sung, primary, Sun, Zhifu, primary, Aubry, Marie Christine, primary, Tang, Hui, primary, Park, Cheol-Hong, primary, Rakhshan, Fariborz, primary, Schultz, Debra A., primary, Kolbert, Christopher P., primary, Lupu, Ruth, primary, Park, Jae Yong, primary, Harris, Curtis C., primary, Yang, Ping, primary, and Jen, Jin, primary

Published
2023
Full Text
View/download PDF

49. Supplementary Figure 4A from Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy

Author

Li, Yafei, primary, Sun, Zhifu, primary, Cunningham, Julie M., primary, Aubry, Marie C., primary, Wampfler, Jason A., primary, Croghan, Gary A., primary, Johnson, Cassandra, primary, Wu, Danli, primary, Aakre, Jeremiah A., primary, Molina, Julian, primary, Wang, Liewei, primary, Pankratz, V. Shane, primary, and Yang, Ping, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results